Bayer completed the acquisition of a 70% stake in Care/of for $225m.

Bayer, a German multinational pharmaceutical and life sciences company, completed the acquisition of a 70% stake in Care/of, a vitamin subscription service provider, for $225m. "We believe this model and product type has the ability to expand into traditional retail channels as we aim to reach new consumers. Together we plan to grow the Care/of business across new channels, new categories and new markets to deliver even more personalized nutrition," Dan Childs, Bayer spokesman.